- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/16 - Animal cells
Patent holdings for IPC class C12N 5/16
Total number of patents in this class: 1306
10-year publication summary
|
77
|
94
|
107
|
109
|
89
|
73
|
59
|
56
|
39
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19859 |
18 |
| Regeneron Pharmaceuticals, Inc. | 4238 |
17 |
| F. Hoffmann-La Roche AG | 7932 |
14 |
| The Trustees of the University of Pennsylvania | 4311 |
13 |
| Amgen Inc. | 4071 |
12 |
| The Board of Trustees of the Leland Stanford Junior University | 6394 |
10 |
| Board of Regents, The University of Texas System | 5760 |
10 |
| The University of British Columbia | 1498 |
10 |
| Abbvie Inc. | 1803 |
9 |
| Arius Research Inc. | 21 |
9 |
| CRISPR Therapeutics AG | 362 |
9 |
| Crystal Bioscience Inc. | 82 |
9 |
| Dana-Farber Cancer Institute, Inc. | 2558 |
9 |
| Genentech, Inc. | 3976 |
8 |
| CHO Plus, Inc. | 14 |
8 |
| Novartis AG | 10882 |
7 |
| The Trustees of Columbia University in the City of New York | 3563 |
7 |
| The Board of Trustees of the University of Illinois | 2685 |
7 |
| E. R. Squibb & Sons, L.L.C. | 119 |
7 |
| ImmunoGen, Inc. | 400 |
7 |
| Other owners | 1106 |